Inflammation in schizophrenia: pathogenetic aspects and therapeutic considerations.
Open accessThe DOI matches its Crossref record; 128 of the 130 references it cites were found in a registry or an index.
Abstract
This paper discusses the current evidence from animal and human studies for a central role of inflammation in schizophrenia. In animal models, pre- or perinatal elicitation of the immune response may increase immune reactivity throughout life, and similar findings have been described in humans. Levels of pro-inflammatory markers, such as cytokines, have been found to be increased in the blood and cerebrospinal fluid of patients with schizophrenia. Numerous epidemiological and clinical studies have provided evidence that various infectious agents are risk factors for schizophrenia and other psychoses. For example, a large-scale epidemiological study performed in Denmark clearly showed that severe infections and autoimmune disorders are such risk factors. The vulnerability-stress-inflammation model may help to explain the role of inflammation in schizophrenia because stress can increase pro-inflammatory cytokines and may even contribute to a chronic pro-inflammatory state. Schizophrenia is characterized by risk genes that promote inflammation and by environmental stress factors and alterations of the immune system. Typical alterations of dopaminergic, serotonergic, noradrenergic, and glutamatergic neurotransmission described in schizophrenia have also been found in low-level neuroinflammation and consequently may be key factors in the generation of schizophrenia symptoms. Further support for the relevance of a low-level neuroinflammatory process in schizophrenia is provided by the loss of central nervous system volume and microglial activation demonstrated in neuroimaging studies. Last but not least, the benefit of anti-inflammatory medications found in some studies and the intrinsic anti-inflammatory and immunomodulatory effects of antipsychotics provide further support for the role of inflammation in this debilitating disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Evidence of altered inflammation-related markers across psychiatric conditions [6–8], along with reports of anti-inflammatory effects from psychotropic medications [9, 10] and the ameliorative impact of anti-inflammatory drugs on psychiatric symptoms [11–14], suggests a strong link between abnormal inflammatory responses and major psychiatric disorders.”
From Inflammatory ratios as predictors of length of hospitalization in psychiatric patients: A multicenter study (2025) · doi:10.1007/s00406-025-02033-9 · cites this paper as [8]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“A growing body of evidence suggests that immune dysfunction and inflammation have been considered to play important roles in the pathogenesis of SCZ and BD (11, 12).”
From Investigation of systemic immune-inflammation index, neutrophil/high-density lipoprotein ratio, lymphocyte/high-density lipoprotein ratio, and monocyte/high-density lipoprotein ratio as indicators of inflammation in patients with schizophrenia and bipolar disorder (2022) · cites this paper as [12]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Changes of some inflammation-related factors (IRFs) have been intensively studied and reviewed in relation to psychiatric disorders1–9.”
From Inflammation-related biomarkers in major psychiatric disorders: a cross-disorder assessment of reproducibility and specificity in 43 meta-analyses (2019) · cites this paper as [6]
The cited source says what the claim attributes to it.
In the citing paper
“Recent evidence suggests the involvement of the immune system in several psychiatric conditions [203–205]; one of the most studied in this respect is depression [206–208].”
From Molecular Characterisation of the Mechanism of Action of Stimulant Drugs Lisdexamfetamine and Methylphenidate on ADHD Neurobiology: A Review (2022) · cites this paper as [203]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Murphy, K., & Weaver, C. (2016) · W.W. Norton eBooks · doi:10.1201/9781315533247 · Cited by 2,258
Vulnerability: A new view of schizophrenia.
Zubin, J., & Spring, B. (1977) · Journal of Abnormal Psychology · doi:10.1037/0021-843x.86.2.103 · Cited by 1,992
Cortical demyelination and diffuse white matter injury in multiple sclerosis
Kutzelnigg, A., Lucchinetti, C. F., Stadelmann, C., Brück, W., Rauschka, H., Bergmann, M., Schmidbauer, M., Parisi, J. E., & Lassmann, H. (2005) · Brain · doi:10.1093/brain/awh641 · Cited by 1,836
Goldsmith, D. R., Rapaport, M. H., & Miller, B. J. (2016) · Molecular Psychiatry · doi:10.1038/mp.2016.3 · Cited by 1,683
Raison, C. L., Rutherford, R. E., Woolwine, B. J., Shuo, C., Schettler, P., Drake, D. F., Haroon, E., & Miller, A. H. (2013) · JAMA Psychiatry · doi:10.1001/2013.jamapsychiatry.4 · Cited by 1,617
Maternal Immune Activation Alters Fetal Brain Development through Interleukin-6
Smith, S. E. P., Li, J., Garbett, K., Mirnics, K., & Patterson, P. H. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.2178-07.2007 · Cited by 1,605
Serologic Evidence of Prenatal Influenza in the Etiology of Schizophrenia
Brown, A. S., Begg, M. D., Gravenstein, S., Schaefer, C. A., Wyatt, R. J., Bresnahan, M., Babulas, V. P., & Susser, E. S. (2004) · Archives of General Psychiatry · doi:10.1001/archpsyc.61.8.774 · Cited by 1,053
The current status of the dopamine hypothesis of schizophrenia
CARLSSON, A. (1988) · Neuropsychopharmacology · doi:10.1016/0893-133x(88)90012-7 · Cited by 958
Neuropharmacology of quinolinic and kynurenic acids.
Stone, T. W. (1993) · Pharmacological Reviews · doi:10.1016/s0031-6997(25)00441-7 · Cited by 948
Cytokine-induced sickness behavior: where do we stand?
Dantzer, R. (2001) · Brain, Behavior, and Immunity · doi:10.1006/brbi.2000.0613 · Cited by 862
Inflammatory cytokine alterations in schizophrenia: a systematic quantitative review
Potvin, S., Stip, E., Sepehry, A. A., Gendron, A., Bah, R., & Kouassi, E. (2008) · Biological Psychiatry · doi:10.1016/j.biopsych.2007.09.024 · Cited by 858
Khandaker, G. M., Pearson, R. M., Zammit, S., Lewis, G., & Jones, P. B. (2014) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2014.1332 · Cited by 846
Steen, R. G., Mull, C., Mcclure, R., Hamer, R. M., & Lieberman, J. A. (2006) · British Journal of Psychiatry · doi:10.1192/bjp.188.6.510 · Cited by 832
Cunningham, C., Wilcockson, D. C., Campion, S., Lunnon, K., & Perry, V. H. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.2614-05.2005 · Cited by 768
Increased cortical kynurenate content in schizophrenia
Schwarcz, R., Rassoulpour, A., Wu, H.-Q., Medoff, D., Tamminga, C. A., & Roberts, R. C. (2001) · Biological Psychiatry · doi:10.1016/s0006-3223(01)01078-2 · Cited by 590
van Berckel, B. N., Bossong, M. G., Boellaard, R., Kloet, R., Schuitemaker, A., Caspers, E., Luurtsema, G., Windhorst, A. D., Cahn, W., Lammertsma, A. A., et al. (2008) · Biological Psychiatry · doi:10.1016/j.biopsych.2008.04.025 · Cited by 582
Benros, M. E., Nielsen, P. R., Nordentoft, M., Eaton, W. W., Dalton, S. O., & Mortensen, P. B. (2011) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2011.11030516 · Cited by 582
Frank, M. G., Baratta, M. V., Sprunger, D. B., Watkins, L. R., & Maier, S. F. (2007) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2006.03.005 · Cited by 578
Neuroinflammation in Schizophrenia-Related Psychosis: A PET Study
Doorduin, J., de Vries, E. F. J., Willemsen, A. T. M., de Groot, J. C., Dierckx, R. A., & Klein, H. C. (2009) · Journal of Nuclear Medicine · doi:10.2967/jnumed.109.066647 · Cited by 559
Maternal Infections and Subsequent Psychosis Among Offspring
Buka, S. L. (2001) · Archives of General Psychiatry · doi:10.1001/archpsyc.58.11.1032 · Cited by 510
Maternal Exposure to Toxoplasmosis and Risk of Schizophrenia in Adult Offspring
Brown, A. S., Schaefer, C. A., Quesenberry, C. P., Liu, L., Babulas, V. P., & Susser, E. S. (2005) · American Journal of Psychiatry · doi:10.1176/appi.ajp.162.4.767 · Cited by 496
Zhou, D., Kusnecov, A. W., Shurin, M. R., DePaoli, M., & Rabin, B. S. (1993) · Endocrinology · doi:10.1210/endo.133.6.8243274 · Cited by 494
Elevated Maternal Interleukin-8 Levels and Risk of Schizophrenia in Adult Offspring
Brown, A. S., Hooton, J., Schaefer, C. A., Zhang, H., Petkova, E., Babulas, V., Perrin, M., Gorman, J. M., & Susser, E. S. (2004) · American Journal of Psychiatry · doi:10.1176/appi.ajp.161.5.889 · Cited by 489
Kynurenic acid levels are elevated in the cerebrospinal fluid of patients with schizophrenia
Erhardt, S., Blennow, K., Nordin, C., Skogh, E., Lindström, L. H., & Engberg, G. (2001) · Neuroscience Letters · doi:10.1016/s0304-3940(01)02242-x · Cited by 471
Ageing and life-long maintenance of T-cell subsets in the face of latent persistent infections.
Nikolich-Žugich, J. (2008) · Nature reviews. Immunology · doi:10.1038/nri2318 · Cited by 463
Pro- versus anti-inflammatory cytokines: myth or reality.
Cavaillon, J. (2001) · PubMed · Cited by 410
Nair, A., & Bonneau, R. H. (2006) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2005.09.012 · Cited by 392
Wang, A. K., & Miller, B. J. (2018) · Schizophrenia Bulletin · doi:10.1093/schbul/sbx035 · Cited by 389
Müller, N., Riedel, M., Scheppach, C., Brandstätter, B., Sokullu, S., Krampe, K., Ulmschneider, M., Engel, R. R., Möller, H.-J., & Schwarz, M. J. (2002) · American Journal of Psychiatry · doi:10.1176/appi.ajp.159.6.1029 · Cited by 388
Self-citationLevkovitz, Y., Mendlovich, S., Riwkes, S., Braw, Y., Levkovitch-Verbin, H., Gal, G., Fennig, S., Treves, I., & Kron, S. (2010) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.08m04666yel · Cited by 387
Steiner, J., Walter, M., Glanz, W., Sarnyai, Z., Bernstein, H.-G., Vielhaber, S., Kästner, A., Skalej, M., Jordan, W., Schiltz, K., et al. (2013) · JAMA Psychiatry · doi:10.1001/2013.jamapsychiatry.86 · Cited by 380
Viruses, schizophrenia, and bipolar disorder
Yolken, R. H., & Torrey, E. F. (1995) · Clinical Microbiology Reviews · doi:10.1128/cmr.8.1.131 · Cited by 356
Efficacy of Anti-inflammatory Agents to Improve Symptoms in Patients With Schizophrenia: An Update
Sommer, I. E., van Westrhenen, R., Begemann, M. J. H., de Witte, L. D., Leucht, S., & Kahn, R. S. (2014) · Schizophrenia Bulletin · doi:10.1093/schbul/sbt139 · Cited by 342
Abbasi, S.-H., Hosseini, F., Modabbernia, A., Ashrafi, M., & Akhondzadeh, S. (2012) · Journal of Affective Disorders · doi:10.1016/j.jad.2012.03.033 · Cited by 339
Neuroinflammation Associated with Aging Sensitizes the Brain to the Effects of Infection or Stress
Sparkman, N. L., & Johnson, R. W. (2008) · Neuroimmunomodulation · doi:10.1159/000156474 · Cited by 332
Increased Levels of Kynurenine and Kynurenic Acid in the CSF of Patients With Schizophrenia
Linderholm, K. R., Skogh, E., Olsson, S. K., Dahl, M.-L., Holtze, M., Engberg, G., Samuelsson, M., & Erhardt, S. (2012) · Schizophrenia Bulletin · doi:10.1093/schbul/sbq086 · Cited by 325
The inflammatory response system in treatment-resistant schizophrenia: increased serum interleukin-6
Lin, A., Kenis, G., Bignotti, S., Tura, G.-J.-B., De Jong, R., Bosmans, E., Pioli, R., Altamura, C., Scharpé, S., & Maes, M. (1998) · Schizophrenia Research · doi:10.1016/s0920-9964(98)00034-6 · Cited by 321
Cytokines, stress and depressive illness: Brain-immune interactions.
Anisman, H., & Merali, Z. (2003) · Annals of Medicine · doi:10.1080/07853890310004075 · Cited by 302
Differentiation of Mesencephalic Progenitor Cells into Dopaminergic Neurons by Cytokines
Ling, Z. D., Potter, E. D., Lipton, J. W., & Carvey, P. M. (1998) · Experimental Neurology · doi:10.1006/exnr.1998.6715 · Cited by 295
The Role of Immune System in Schizophrenia
Muller, N., & J. Schwarz, M. (2010) · Current Immunology Reviews · doi:10.2174/157339510791823673 · Cited by 291
Self-citationAKHONDZADEH, S., TABATABAEE, M., AMINI, H., AHMADIABHARI, S., ABBASI, S., & BEHNAM, B. (2007) · Schizophrenia Research · doi:10.1016/j.schres.2006.11.016 · Cited by 289
Cortisol and Inflammatory Biomarkers Predict Poor Treatment Response in First Episode Psychosis
Mondelli, V., Ciufolini, S., Belvederi Murri, M., Bonaccorso, S., Di Forti, M., Giordano, A., Marques, T. R., Zunszain, P. A., Morgan, C., Murray, R. M., et al. (2015) · Schizophrenia Bulletin · doi:10.1093/schbul/sbv028 · Cited by 286
Chaudhry, I. B., Hallak, J., Husain, N., Minhas, F., Stirling, J., Richardson, P., Dursun, S., Dunn, G., & Deakin, B. (2012) · Journal of Psychopharmacology · doi:10.1177/0269881112444941 · Cited by 279
Theories of schizophrenia: a genetic-inflammatory-vascular synthesis
Hanson, D. R., & Gottesman, I. I. (2005) · BMC Medical Genetics · doi:10.1186/1471-2350-6-7 · Cited by 276
Brown, A. S., Schaefer, C. A., Wyatt, R. J., Goetz, R., Begg, M. D., Gorman, J. M., & Susser, E. S. (2000) · Schizophrenia Bulletin · doi:10.1093/oxfordjournals.schbul.a033453 · Cited by 273
Laan, W., Grobbee, D. E., Selten, J.-P., Heijnen, C. J., Kahn, R. S., & Burger, H. (2010) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.09m05117yel · Cited by 264
Association Between Prenatal Exposure to Bacterial Infection and Risk of Schizophrenia
Sorensen, H. J., Mortensen, E. L., Reinisch, J. M., & Mednick, S. A. (2009) · Schizophrenia Bulletin · doi:10.1093/schbul/sbn121 · Cited by 261
Meyer, U., Schwarz, M. J., & Müller, N. (2011) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2011.06.003 · Cited by 258
Self-citationThe evolutionary significance of depression in Pathogen Host Defense (PATHOS-D)
Raison, C. L., & Miller, A. H. (2013) · Molecular Psychiatry · doi:10.1038/mp.2012.2 · Cited by 253
Impaired Kynurenine Pathway Metabolism in The Prefrontal Cortex of Individuals With Schizophrenia
Sathyasaikumar, K. V., Stachowski, E. K., Wonodi, I., Roberts, R. C., Rassoulpour, A., McMahon, R. P., & Schwarcz, R. (2011) · Schizophrenia Bulletin · doi:10.1093/schbul/sbq112 · Cited by 253
Müller, N., Krause, D., Dehning, S., Musil, R., Schennach-Wolff, R., Obermeier, M., Möller, H.-J., Klauss, V., Schwarz, M. J., & Riedel, M. (2010) · Schizophrenia Research · doi:10.1016/j.schres.2010.04.015 · Cited by 250
Self-citationDalman, C., Allebeck, P., Gunnell, D., Harrison, G., Kristensson, K., Lewis, G., Lofving, S., Rasmussen, F., Wicks, S., & Karlsson, H. (2008) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2007.07050740 · Cited by 247
Winter, C., Djodari-Irani, A., Sohr, R., Morgenstern, R., Feldon, J., Juckel, G., & Meyer, U. (2009) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145708009206 · Cited by 242
Maternal Exposure to Herpes Simplex Virus and Risk of Psychosis Among Adult Offspring
Buka, S. L., Cannon, T. D., Torrey, E. F., & Yolken, R. H. (2008) · Biological Psychiatry · doi:10.1016/j.biopsych.2007.09.022 · Cited by 233
Prenatal Exposure to Maternal Genital and Reproductive Infections and Adult Schizophrenia
Babulas, V., Factor-Litvak, P., Goetz, R., Schaefer, C. A., & Brown, A. S. (2006) · American Journal of Psychiatry · doi:10.1176/ajp.2006.163.5.927 · Cited by 233
Antibodies to infectious agents in individuals with recent onset schizophrenia
Leweke, F. M., Gerth, C. W., Koethe, D., Klosterk�tter, J., Ruslanova, I., Krivogorsky, B., Torrey, E. F., & Yolken, R. H. (2004) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-004-0481-6 · Cited by 226
Ellman, L. M., Deicken, R. F., Vinogradov, S., Kremen, W. S., Poole, J. H., Kern, D. M., Tsai, W. Y., Schaefer, C. A., & Brown, A. S. (2010) · Schizophrenia Research · doi:10.1016/j.schres.2010.05.014 · Cited by 225
Age and neuroinflammation: a lifetime of psychoneuroimmune consequences
Godbout, J. P., & Johnson, R. W. (2009) · Immunology and Allergy Clinics of North America · doi:10.1016/j.iac.2009.02.007 · Cited by 224
Nonaffective Psychosis After Prenatal Exposure to Rubella
Brown, A. S., Cohen, P., Greenwald, S., & Susser, E. (2000) · American Journal of Psychiatry · doi:10.1176/appi.ajp.157.3.438 · Cited by 219
Serologic Evidence of Prenatal Influenza in the Etiology of Schizophrenia
Brown, A. S., Begg, M. D., Gravenstein, S., Schaefer, C. A., Wyatt, R. J., Bresnahan, M., Babulas, V. P., & Susser, E. S. (2005) · Obstetrical & Gynecological Survey · doi:10.1097/01.ogx.0000151642.60544.d2 · Cited by 216
Felger, J. C., Mun, J., Kimmel, H. L., Nye, J. A., Drake, D. F., Hernandez, C. R., Freeman, A. A., Rye, D. B., Goodman, M. M., Howell, L. L., et al. (2013) · Neuropsychopharmacology · doi:10.1038/npp.2013.115 · Cited by 214
Zhang, X. Y., Zhou, D. F., Cao, L. Y., Wu, G. Y., & Shen, Y. C. (2005) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300756 · Cited by 209
Nitta, M., Kishimoto, T., Müller, N., Weiser, M., Davidson, M., Kane, J. M., & Correll, C. U. (2013) · Schizophrenia Bulletin · doi:10.1093/schbul/sbt070 · Cited by 204
Self-citation(1995) · American Journal of Psychiatry · doi:10.1176/ajp.152.9.1291 · Cited by 204
Autoimmune diseases and infections as risk factors for schizophrenia
Benros, M. E., Mortensen, P. B., & Eaton, W. W. (2012) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2012.06638.x · Cited by 186
Sommer, I. E., de Witte, L., Begemann, M., & Kahn, R. S. (2012) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.10r06823 · Cited by 182
Neuro-immune crosstalk in CNS diseases
Kerschensteiner, M., Meinl, E., & Hohlfeld, R. (2008) · Neuroscience · doi:10.1016/j.neuroscience.2008.09.009 · Cited by 179
Takano, A., Arakawa, R., Ito, H., Tateno, A., Takahashi, H., Matsumoto, R., Okubo, Y., & Suhara, T. (2010) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145710000313 · Cited by 175
Schizophrenia and viral infection during neurodevelopment: a focus on mechanisms
Pearce, B. D. (2001) · Molecular Psychiatry · doi:10.1038/sj.mp.4000956 · Cited by 171
Versijpt, J. J., Dumont, F., van Laere, K. J., Decoo, D., Santens, P., Audenaert, K., Achten, E., Slegers, G., Dierckx, R., & Korf, J. (2003) · European Neurology · doi:10.1159/000070857 · Cited by 166
Cytokine regulation of embryonic rat dopamine and serotonin neuronal survival in vitro
Jarskog, L. F., Xiao, H., Wilkie, M. B., Lauder, J. M., & Gilmore, J. H. (1997) · International Journal of Developmental Neuroscience · doi:10.1016/s0736-5748(97)00029-4 · Cited by 163
The Psychiatric Symptoms of Rheumatic Fever
Mercadante, M. T., Busatto, G. F., Lombroso, P. J., Prado, L., Rosário-Campos, M. C., do Valle, R., Marques-Dias, M. J., Kiss, M. H., Leckman, J. F., & Miguel, E. C. (2000) · American Journal of Psychiatry · doi:10.1176/appi.ajp.157.12.2036 · Cited by 159
Reconceptualization of translocator protein as a biomarker of neuroinflammation in psychiatry
Notter, T., Coughlin, J. M., Sawa, A., & Meyer, U. (2017) · Molecular Psychiatry · doi:10.1038/mp.2017.232 · Cited by 156
The role of microglial activation in disease progression
Correale, J. D. (2014) · Multiple Sclerosis Journal · doi:10.1177/1352458514533230 · Cited by 151
Duration of illness and treatment effects on hippocampal volume in male patients with schizophrenia
Chakos, M., Schobel, S., Gu, H., Gerig, G., Bradford, D. W., Charles, C. H., & Lieberman, J. A. (2005) · The British Journal of Psychiatry · doi:10.1192/bjp.186.1.26 · Cited by 149
Anderson, G., Berk, M., Dodd, S., Bechter, K., Altamura, A. C., Dell’Osso, B. M., Kanba, S., Monji, A., Fatemi, S. H., Buckley, P. F., et al. (2012) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2012.10.008 · Cited by 149
Self-citationDiagnosis and pathogenesis of CNS lupus
van Dam, A. P. (1991) · Rheumatology International · doi:10.1007/bf00290244 · Cited by 141
A Lifespan Approach to Neuroinflammatory and Cognitive Disorders: A Critical Role for Glia
Bilbo, S. D., Smith, S. H., & Schwarz, J. M. (2011) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-011-9299-y · Cited by 140
Cytokine-induced conversion of mesencephalic-derived progenitor cells into dopamine neurons
Potter, E. D., Ling, Z. D., & Carvey, P. M. (1999) · Cell and Tissue Research · doi:10.1007/s004410051285 · Cited by 140
Metcalf, S. A., Jones, P. B., Nordström, T., Timonen, M., Mäki, P. H., Miettunen, J., Jääskeläinen, E., Järvelin, M., Štochl, J., Murray, G. K., et al. (2016) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2016.09.008 · Cited by 138
Celecoxib Augmentation of Continuously Ill Patients with Schizophrenia
Rapaport, M. H., Delrahim, K. K., Bresee, C. J., Maddux, R. E., Ahmadpour, O. A., & Dolnak, D. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.02.024 · Cited by 137
Clinical effects of COX?2 inhibitors on cognition in schizophrenia
M�ller, N., Riedel, M. J., Schwarz, M., & Engel, R. R. (2004) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-004-0548-4 · Cited by 135
Self-citationExposure to Prenatal and Childhood Infections and the Risk of Schizophrenia
Westergaard, T., Mortensen, P. B., Pedersen, C. B., Wohlfahrt, J., & Melbye, M. (1999) · Archives of General Psychiatry · doi:10.1001/archpsyc.56.11.993 · Cited by 133
Meehan, C. L., Harms, L. R., Frost, J. D., Barreto, R., Todd, J., Schall, U., Weickert, C. S., Zavitsanou, K., Michie, P. T., & Hodgson, D. M. (2016) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2016.07.144 · Cited by 132
Dual role of inflammation in CNS disease
Hohlfeld, R., Kerschensteiner, M., & Meinl, E. (2007) · Neurology · doi:10.1212/01.wnl.0000275234.43506.9b · Cited by 128
Gogtay, N., Lu, A., Leow, A. D., Klunder, A. D., Lee, A. D., Chavez, A., Greenstein, D., Giedd, J. N., Toga, A. W., Rapoport, J. L., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0806485105 · Cited by 125
COX-2 inhibitors as antidepressants and antipsychotics: clinical evidence.
Müller, N. (2010) · PubMed · Cited by 122
Self-citationMeyer, U., & Feldon, J. (2009) · Psychopharmacology · doi:10.1007/s00213-009-1504-9 · Cited by 119
The immunological basis of glutamatergic disturbance in schizophrenia: towards an integrated view
Müller, N., & Schwarz, M. (2007) · Springer eBooks · doi:10.1007/978-3-211-73574-9_33 · Cited by 117
Self-citationMüller, N. (1995) · Schizophrenia Research · doi:10.1016/0920-9964(94)00045-a · Cited by 117
Self-citationCollste, K., Plavén‐Sigray, P., Fatouros‐Bergman, H., Victorsson, P. I., Schain, M., Forsberg, A., Amini, N., Aeinehband, S., Farde, L., Flyckt, L., et al. (2017) · Molecular Psychiatry · doi:10.1038/mp.2016.247 · Cited by 117
Myint, A.-M., Schwarz, M., Verkerk, R. M., Mueller, H. H., Zach, J., Scharpé, S., Steinbusch, H. W. M., Leonard, B. E., & Kim, Y. K. (2011) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2011.05.005 · Cited by 116
Meisenzahl, E. M., Rujescu, D., Kirner, A., Giegling, I., Kathmann, N., Leinsinger, G. L., Maag, K. P., Hegerl, U., Hahn, K. M., & Möller, H. (2001) · American Journal of Psychiatry · doi:10.1176/appi.ajp.158.8.1316 · Cited by 111
Maternal infection during pregnancy and schizophrenia
Boksa, P. (2008) · Journal of Psychiatry and Neuroscience · doi:10.1139/jpn.0818 · Cited by 106
Condray, R., Dougherty, G. G., Keshavan, M. S., Reddy, R. D., Haas, G. L., Montrose, D. M., Matson, W. R., McEvoy, J. P., Kaddurah‐Daouk, R., & Yao, J. K. (2011) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145710001689 · Cited by 105
Strauss, K. I., & Marini, A. M. (2002) · Journal of Neurotrauma · doi:10.1089/089771502753754091 · Cited by 102
Improvement by minocycline of methamphetamine-induced impairment of recognition memory in mice
Mizoguchi, H., Takuma, K., Fukakusa, A., Ito, Y., Nakatani, A., Ibi, D., Kim, H., & Yamada, K. (2007) · Psychopharmacology · doi:10.1007/s00213-007-0955-0 · Cited by 97
Soulet, D., & Rivest, S. (2008) · Current Biology · doi:10.1016/j.cub.2008.04.047 · Cited by 97
Meinl, E., Krumbholz, M., Derfuss, T. J., Junker, A., & Hohlfeld, R. (2008) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2008.06.032 · Cited by 96
Kynurenine pathway in schizophrenia: pathophysiological and therapeutic aspects
Muller, N., Myint, A.-M., & J. Schwarz, M. (2011) · Current Pharmaceutical Design · doi:10.2174/138161211795049552 · Cited by 94
Self-citationGrey matter changes can improve the prediction of schizophrenia in subjects at high risk
Job, D. E., Whalley, H. C., McIntosh, A. M., Owens, D. G. C., Johnstone, E. C., & Lawrie, S. M. (2006) · BMC Medicine · doi:10.1186/1741-7015-4-29 · Cited by 93
Körschenhausen, D. A., Hampel, H. J., Ackenheil, M., Penning, R., & Müller, N. (1996) · Schizophrenia Research · doi:10.1016/0920-9964(95)00073-9 · Cited by 86
Self-citationVincent, A. C., & Bien, C. G. (2008) · The Lancet Neurology · doi:10.1016/s1474-4422(08)70225-4 · Cited by 85
The Risk for Schizophrenia From Childhood and Adult Infections
Brown, A. S. (2008) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2007.07101637 · Cited by 78
Neuroimmune–endocrine crosstalk in schizophrenia and mood disorders
Müller, N., & Schwarz, M. (2006) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.6.7.1017 · Cited by 76
Self-citationThe association of infectious agents and schizophrenia
Krause, D., Matz, J., Weidinger, E., Wagner, J., Wildenauer, A., Obermeier, M., Riedel, M. J., & Müller, N. (2010) · The World Journal of Biological Psychiatry · doi:10.3109/15622971003653246 · Cited by 74
Self-citationChronic neuroleptic treatment reduces endogenous kynurenic acid levels in rat brain
Ceresoli‐Borroni, G., Rassoulpour, A., Wu, H., Guidetti, P., & Schwarcz, R. M. (2006) · Journal of Neural Transmission · doi:10.1007/s00702-005-0432-z · Cited by 72
Hayley, S. P., Wall, P. M., & Anisman, H. (2002) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2002.01936.x · Cited by 64
Olsson, S. K., Andersson, A., Linderholm, K. R., Holtze, M., Nilsson-Todd, L. K., Schwieler, L., Olsson, E., Larsson, K., Engberg, G., & Erhardt, S. (2008) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145708009383 · Cited by 60
Perry, V. H. (2006) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2006.08.004 · Cited by 55
Childhood meningitis, brain maturation and the risk of psychosis*
Gattaz, W. F., Abrah�o, A. L., & Foccacia, R. (2004) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-004-0431-3 · Cited by 54
Administration of Interleukin‐1 at Birth Affects Dopaminergic Neurons in Adult Mice a
Kabiersch, A., Furukawa, H., del Rey, A., & Besedovsky, H. O. (1998) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1998.tb09556.x · Cited by 50
The Case for Adjunctive Monoclonal Antibody Immunotherapy in Schizophrenia
Miller, B. J., & Buckley, P. F. (2016) · Psychiatric Clinics of North America · doi:10.1016/j.psc.2016.01.003 · Cited by 47
Herpes simplex type 2 virus encephalitis presenting as psychosis
Oommen, K. J., Johnson, P. C., & Ray, C. G. (1982) · The American Journal of Medicine · doi:10.1016/0002-9343(82)90751-3 · Cited by 44
Wildenauer, D. B., Körschenhausen, D. A., Hoechtlen, W., Ackenheil, M., Kehl, M., & Lottspeich, F. (1991) · Electrophoresis · doi:10.1002/elps.1150120706 · Cited by 41
Possible anti-catatonic effects of minocycline in patients with schizophrenia
Ahuja, N., & Carroll, B. T. (2007) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2007.01.018 · Cited by 41
Adjunctive Recombinant Human Interferon Gamma-1b for Treatment-Resistant Schizophrenia in 2 Patients
Grüber, L., Bunse, T., Weidinger, E., Reichard, H., & Müller, N. (2014) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.14l09005 · Cited by 38
Self-citationMüller, N., & Bechter, K. (2013) · Neurology Psychiatry and Brain Research · doi:10.1016/j.npbr.2013.04.004 · Cited by 37
Self-citationPsychiatric disorders in the encephalitic form of multiple sclerosis
Felgenhauer, K. (1990) · Journal of Neurology · doi:10.1007/bf00319661 · Cited by 36
Müller, N., von Gizycki-Nienhaus, B., Günther, W., & Meurer, M. (1992) · Biological Psychiatry · doi:10.1016/0006-3223(92)90160-2 · Cited by 34
Self-citationPsychosis following acute Sydenham’s chorea
Teixeira, A. L., Maia, D. P., & Cardoso, F. (2006) · European Child & Adolescent Psychiatry · doi:10.1007/s00787-006-0566-z · Cited by 33
Interleukin‐1, but Not Stress, Stimulates Glucocorticoid Output during Early Postnatal Life in Micea
Furukawa, H., del Rey, A., MONGE‐ARDITI, G., & Besedovsky, H. O. (1998) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1998.tb09555.x · Cited by 33
Neuroprogression in Schizophrenia and Psychotic Disorders: The Possible Role of Inflammation
Müller, N. (2017) · Modern trends in psychiatry · doi:10.1159/000470802 · Cited by 31
Self-citationKerbeshian, J., Burd, L., & Tait, A. (2007) · The World Journal of Biological Psychiatry · doi:10.1080/15622970601182652 · Cited by 17
Therapieresistente Depression mit Fatigue
Bechter, K., Bindl, A., Horn, M., & Schreiner, V. (2006) · Der Nervenarzt · doi:10.1007/s00115-006-2178-8 · Cited by 16
Schizophreniform Disorder with Cerebrospinal Fluid PCR Positivity for Herpes Simplex Virus Type 1
Chiveri, L., Sciacco, M., & Prelle, A. C. (2003) · European Neurology · doi:10.1159/000073062 · Cited by 14
Cerebral involvement of scleroderma presenting as schizophrenia-like psychosis
Müller, N., von Gizycki-Nienhaus, B., Botschev, C., & Meurer, M. (1993) · Schizophrenia Research · doi:10.1016/0920-9964(93)90054-m · Cited by 14
Self-citation[An adult case suspected of recurrent measles encephalitis with psychiatric symptoms].
Hiroshi, H., Seiji, K., Toshihiro, K., & Nobuo, K. (2003) · PubMed · Cited by 12
Cited by
Wang, Q., Xu, R., & Volkow, N. D. (2021) · World Psychiatry · doi:10.1002/wps.20806 · Cited by 617
Yuan, N., Chen, Y., Xia, Y., Dai, J., & Liu, C. (2019) · Translational Psychiatry · doi:10.1038/s41398-019-0570-y · Cited by 428
Association of Psychiatric Disorders With Mortality Among Patients With COVID-19
Nemani, K., Li, C., Olfson, M., Blessing, E. M., Razavian, N., Chen, J., Petkova, E., & Goff, D. C. (2021) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2020.4442 · Cited by 375
Cytokine Alterations in Schizophrenia: An Updated Review
Momtazmanesh, S., Zare-Shahabadi, A., & Rezaei, N. (2019) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2019.00892 · Cited by 276
Marx, W., Veronese, N., Kelly, J. T., Smith, L., Hockey, M., Collins, S., Trakman, G. L., Hoare, E., Teasdale, S. B., Wade, A., et al. (2021) · Advances in Nutrition · doi:10.1093/advances/nmab037 · Cited by 242
Metadata
- Authors
- Müller, N.
- Affiliations
- Ludwig-Maximilians-Universität München (DE)
- Corresponding author
- Müller, Norbert
- ORCID
- Müller, Norbert
- Venue
- Schizophrenia Bulletin
- Publisher
- Oxford University Press (OUP)
- Published
- 2018-04-10
- Volume
- 44
- Issue
- 5
- Pages
- 973-982
- ISSN
- 0586-7614 (ISSN-L)
- 1745-1701
- PMC
- PMC6101562
- OpenAlex
- W2888647009
- Cited by
- 648
- References
- 130
- Citations by year
- 2026: 62 · 2025: 88 · 2024: 92 · 2023: 116 · 2022: 102 · 2021: 98 · 2020: 62 · 2019: 18 · 2018: 9
- FWCI
- 4.08
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model (vor)
- Locations
- Schizophrenia Bulletin (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Neuroscience › Biological Psychiatry › Tryptophan and brain disorders
- Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Keywords
- schizophrenia, neuroinflammation
- MeSH terms
- Animals, Anti-Inflammatory Agents, Humans, Inflammation, Schizophrenia
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.